COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Bausch Health Companies Inc. and Salix Pharmaceuticals win U.S. Court of Appeals case over XIFAXAN, affirming FDA approval delay until Oct. 2029. Statements from CEOs included -
-
-
-
-
-
-
